We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: age
MedXY News
EnglishTag

age

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Synergistic Impact of Age and Nerve Degeneration on Bell’s Palsy Recovery: Clinical Implications
NeurologyageBell's palsy

Synergistic Impact of Age and Nerve Degeneration on Bell’s Palsy Recovery: Clinical Implications

By MedXY|Sep 13, 2026

Older adults with severe nerve impairment in Bell’s palsy experience markedly poorer recovery, highlighting the critical role of early, aggressive intervention.

TERT Promoter Variants and Age: Refining Prognostic Precision in Papillary Thyroid Carcinoma
newsTERT promoterage

TERT Promoter Variants and Age: Refining Prognostic Precision in Papillary Thyroid Carcinoma

By MedXY|Aug 23, 2026

This analysis reveals that TERT promoter mutations, increasingly prevalent with age, better predict poor outcomes in papillary thyroid carcinoma than age alone, offering enhanced risk stratification for clinical management.

Reevaluating Age as a Prognostic Marker in Molecularly Defined Lower-Grade Gliomas
Neurologyagelower-grade glioma

Reevaluating Age as a Prognostic Marker in Molecularly Defined Lower-Grade Gliomas

By MedXY|Aug 13, 2026

This article examines how age, traditionally considered a high-risk factor in lower-grade gliomas, influences prognosis and treatment decisions in the molecular era, highlighting the importance of IDH mutation status.

Age-Related Impact of Treatment Intensification on Survival in Metastatic Hormone-Sensitive Prostate Cancer
newsageandrogen receptor pathway inhibitors

Age-Related Impact of Treatment Intensification on Survival in Metastatic Hormone-Sensitive Prostate Cancer

By MedXY|Oct 30, 2025

Systemic treatment intensification improves overall survival in metastatic hormone-sensitive prostate cancer, but its benefit varies by age and disease volume. Older men, particularly with low-volume disease, may have limited survival gains

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story